Ignite Creation Date:
2024-05-06 @ 8:43 AM
Last Modification Date:
2024-10-26 @ 12:04 PM
Study NCT ID:
NCT02807181
Status:
COMPLETED
Last Update Posted:
2023-04-12
First Post:
2016-05-13
Brief Title:
SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Sponsor:
Sirtex Medical
Organization:
Sirtex Medical
Organization Data
Organization:
Sirtex Medical
Class:
INDUSTRY
Study ID:
STX0115
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sirtex Medical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None